NCT05080465View on ClinicalTrials.gov

Long Term Follow up Mesenchymal Stem Cell Therapy for Patients Virus-related Liver Cirrhosis

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

700

Participants

Timeline

Start Date

December 2, 2018

Primary Completion Date

October 7, 2024

Study Completion Date

December 31, 2025

Conditions

Liver Cirrhosis

Interventions

BIOLOGICAL

Autologous BM MSC

A total of 100-200ml will be harvested from the subject, in either a single or multiple punctures. This will be processed for autologous MSC infusion.

Trial Locations (1)

Unknown

Institute of Bio-Stem Cell Rehabilitation, Kharkiv

All Listed Sponsors

lead

Ukraine Association of Biobank

OTHER